Brind.

The Tennessee Department of Treasury bought a new position in stock, while Citigroup reaffirmed its 'outperform' rating and Leerink Partners set a $43.00 price objective.

1 report, 1 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Tennessee Department of Treasury Sutro Biopharma Citigroup Leerink partners

Keep exploring

The entities involved

Tennessee Department of Treasury
Tennessee state department

Nothing else this week.
Sutro Biopharma
company

Nothing else this week.
Citigroup
American investment bank and financial services corporation
- Royal Bank of Canada dropped its price objective for Crown Castle Inc., while Citigroup reiterated an outperform rating.Sun 13:27
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.Sun 07:35
Leerink partners
U.S. investment bank
- Summit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.Sun 19:40
- Intuitive Surgical received a Buy rating from Leerink partners, citing increased da Vinci placements and potential benefits from Trump-era tariffs.Sat 07:31

Related events

Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.Oct 9

Coverage

Newest first; wire copies grouped

Jul 9dailypolitical.com